What is Tenax Therapeutics, Inc.'s Market Cap?

Tenax Therapeutics, Inc.'s Market Cap is $74.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tenax Therapeutics, Inc.'s Revenue (TTM)?

Tenax Therapeutics, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Tenax Therapeutics, Inc.'s Net Income (TTM)?

Tenax Therapeutics, Inc.'s Net Income (TTM) is -$64.9M, based on as-reported figures from SEC (XBRL) filings.

What is Tenax Therapeutics, Inc.'s Diluted EPS (TTM)?

Tenax Therapeutics, Inc.'s Diluted EPS (TTM) is -1.73, based on as-reported figures from SEC (XBRL) filings.

Tenax Therapeutics, Inc. (TENX) Financial Statements

Tenax Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S78GM3

XNAS · usd

1.98▲ 0.04 (2.06%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.94

Day's Range1.94 – 2.18

52-Week Range1.31 – 19.40

Volume7.4M

Avg Volume8.7M

Share Statistics

Shares Outstanding

Employees16

ExchangeXNAS

Listed1995-02-01

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tenax Therapeutics, Inc. (TENX)

What is Tenax Therapeutics, Inc.'s Market Cap?: Tenax Therapeutics, Inc.'s Market Cap is $74.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Revenue (TTM)?: Tenax Therapeutics, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Net Income (TTM)?: Tenax Therapeutics, Inc.'s Net Income (TTM) is -$64.9M, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Diluted EPS (TTM)?: Tenax Therapeutics, Inc.'s Diluted EPS (TTM) is -1.73, based on as-reported figures from SEC (XBRL) filings.